Steinar Aamdal Selected Research

Steinar Aamdal Research Topics

Disease

25	Neoplasms (Cancer) 05/2022 - 03/2004
21	Melanoma (Melanoma, Malignant) 01/2022 - 06/2005
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2004
3	Neoplasm Metastasis (Metastasis) 01/2016 - 06/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2022
2	Hypersensitivity (Allergy) 01/2016 - 07/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2005 - 12/2002
1	Alveolar Soft Part Sarcoma 05/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Alveolar Rhabdomyosarcoma 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 09/2013
1	Brain Neoplasms (Brain Tumor) 09/2013
1	Neutropenia 06/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2009
1	Necrosis 11/2006
1	Lymphatic Metastasis 11/2006
1	Esophagitis 10/2005

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2022 - 06/2005
8	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 12/2006
7	AntigensIBA 01/2020 - 06/2005
7	Messenger RNA (mRNA)IBA 01/2016 - 06/2005
6	IpilimumabIBA 01/2022 - 11/2011
5	Peptides (Polypeptides)IBA 01/2021 - 12/2006
4	Docetaxel (Taxotere)FDA Link 04/2009 - 10/2005
3	EpitopesIBA 01/2021 - 06/2011
3	CytokinesIBA 01/2016 - 05/2007
3	InterferonsIBA 08/2013 - 10/2007
2	CrizotinibIBA 05/2022 - 01/2018
2	Cancer VaccinesIBA 01/2021 - 06/2005
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 06/2015 - 11/2011
2	Interferon alpha-2 (Roferon-A)FDA Link 02/2015 - 02/2011
2	Etoposide (VP 16)FDA LinkGeneric 05/2005 - 12/2002
2	Cisplatin (Platino)FDA LinkGeneric 05/2005 - 12/2002
2	Epirubicin (Ellence)FDA LinkGeneric 05/2005 - 12/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2005 - 12/2002
2	Vincristine (Oncovin)FDA LinkGeneric 05/2005 - 12/2002
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	AndrogensIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	SurvivinIBA 01/2016
1	OsteopontinIBA 06/2015
1	Interferon-alpha (Interferon Alfa)IBA 06/2015
1	Dacarbazine (DIC)FDA LinkGeneric 04/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Codon (Codons)IBA 01/2014
1	G(M2) Ganglioside (Ganglioside GM2)IBA 10/2013
1	saponin QA-21V1 (QS21)IBA 10/2013
1	SuspensionsIBA 09/2013
1	AZD8330IBA 05/2013
1	Pharmaceutical PreparationsIBA 12/2011
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2011
1	Monoclonal AntibodiesIBA 11/2011
1	Viscum ribosome inactivating proteinIBA 07/2011
1	Temozolomide (Temodar)FDA LinkGeneric 07/2011
1	Protein Subunit VaccinesIBA 07/2011
1	EnzymesIBA 06/2009
1	AntibodiesIBA 06/2009
1	Antinuclear AntibodiesIBA 06/2009
1	AutoantibodiesIBA 06/2009
1	anti-thyroglobulinIBA 06/2009
1	ImmunosorbentsIBA 06/2009
1	5'-oleoyl cytarabineIBA 01/2009
1	thiamine triphosphorate (TTP)IBA 01/2009
1	Epithelial Cell Adhesion MoleculeIBA 08/2008
1	GV1001 peptideIBA 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2006
1	Melphalan (Alkeran)FDA LinkGeneric 11/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2006
1	Taxoids (Taxanes)IBA 01/2006
1	PolyaminesIBA 06/2005
1	RNA (Ribonucleic Acid)IBA 06/2005
1	Adenosylmethionine DecarboxylaseIBA 06/2005
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2005
1	4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664)IBA 06/2005
1	Indicators and Reagents (Reagents)IBA 06/2004

Therapy/Procedure

12	Therapeutics 05/2022 - 10/2007
6	Immunotherapy 01/2020 - 06/2011
6	Drug Therapy (Chemotherapy) 07/2011 - 12/2002
4	Radiotherapy 04/2009 - 03/2004
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2016
1	Chemoradiotherapy 11/2011
1	Lymph Node Excision (Lymph Node Dissection) 11/2006
1	Transcranial Direct Current Stimulation 06/2005